References
1. Cheng TO. Percutaneous transfemoral venous cardiac pacing. A simple
and practical method. Chest 1971;60:73-8.
2. Harrigan RA, Chan TC, Moonblatt S, Vilke GM, Ufberg JW. Temporary
transvenous pacemaker placement in the Emergency Department. J Emerg Med
2007;32:105-11.
3. Gammage MD. Temporary cardiac pacing. Heart 2000;83:715-20.
4. Kusumoto FM, Schoenfeld MH, Barrett C et al. 2018 ACC/AHA/HRS
Guideline on the Evaluation and Management of Patients With Bradycardia
and Cardiac Conduction Delay: Executive Summary: A Report of the
American College of Cardiology/American Heart Association Task Force on
Clinical Practice Guidelines, and the Heart Rhythm Society. Circulation
2019;140:e333-e381.
5. Tjong FVY, de Ruijter UW, Beurskens NEG, Knops RE. A comprehensive
scoping review on transvenous temporary pacing therapy. Neth Heart J
2019;27:462-473.
6. Suarez K, Banchs JE. A Review of Temporary Permanent Pacemakers and a
Comparison with Conventional Temporary Pacemakers. J Innov Card Rhythm
Manag 2019;10:3652-3661.
7. McCann P. A review of temporary cardiac pacing wires. Indian Pacing
Electrophysiol J 2007;7:40-9.
8. de Cock CC, Van Campen CM, In’t Veld JA, Visser CA. Utility and
safety of prolonged temporary transvenous pacing using an
active-fixation lead: comparison with a conventional lead. Pacing Clin
Electrophysiol 2003;26:1245-8.
9. Metkus TS, Schulman SP, Marine JE, Eid SM. Complications and Outcomes
of Temporary Transvenous Pacing: An Analysis of > 360,000
Patients From the National Inpatient Sample. Chest 2019;155:749-757.
10. Ng ACC, Lau JK, Chow V, Adikari D, Brieger D, Kritharides L.
Outcomes of 4838 patients requiring temporary transvenous cardiac
pacing: A statewide cohort study. Int J Cardiol 2018;271:98-104.
11. Braun MU, Rauwolf T, Bock M et al. Percutaneous lead implantation
connected to an external device in stimulation-dependent patients with
systemic infection–a prospective and controlled study. Pacing Clin
Electrophysiol 2006;29:875-9.
12. Detsky ME, Harhay MO, Bayard DF et al. Six-Month Morbidity and
Mortality among Intensive Care Unit Patients Receiving Life-Sustaining
Therapy. A Prospective Cohort Study. Ann Am Thorac Soc
2017;14:1562-1570.
13. Murphy JJ. Current practice and complications of temporary
transvenous cardiac pacing. BMJ 1996;312:1134.
14. Hermans G, Van Aerde N, Meersseman P et al. Five-year mortality and
morbidity impact of prolonged versus brief ICU stay: a propensity score
matched cohort study. Thorax 2019;74:1037-1045.
15. Kim DY, Lee MH, Lee SY, Yang BR, Kim HA. Survival rates following
medical intensive care unit admission from 2003 to 2013: An
observational study based on a representative population-based sample
cohort of Korean patients. Medicine (Baltimore) 2019;98:e17090.
16. Moitra VK, Guerra C, Linde-Zwirble WT, Wunsch H. Relationship
Between ICU Length of Stay and Long-Term Mortality for Elderly ICU
Survivors. Crit Care Med 2016;44:655-62.
17. DiSario JA. Future considerations in aspiration pneumonia in the
critically ill patient: what is not known, areas for future research,
and experimental methods. JPEN J Parenter Enteral Nutr 2002;26:S75-8;
discussion S79.
18. Mitchell BG, Ferguson JK, Anderson M, Sear J, Barnett A. Length of
stay and mortality associated with healthcare-associated urinary tract
infections: a multi-state model. J Hosp Infect 2016;93:92-9.
19. Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer
prophylaxis in the new millennium: a systematic review and
meta-analysis. Crit Care Med 2010;38:2222-8.
20. Wollschlager CM, Conrad AR, Khan FA. Common complications in
critically ill patients. Dis Mon 1988;34:221-93.
21. Paton F, Chambers D, Wilson P et al. Initiatives to reduce length of
stay in acute hospital settings: a rapid synthesis of evidence relating
to enhanced recovery programmes. Southampton (UK), 2014.
22. Jackson JC, Girard TD, Gordon SM et al. Long-term cognitive and
psychological outcomes in the awakening and breathing controlled trial.
Am J Respir Crit Care Med 2010;182:183-91.
23. Orsbourn G, Lever N, Harding SA. Use of tunnelled active fixation
leads allows reliable temporary pacing over prolonged periods. Intern
Med J 2008;38:735-8.
24. Kornberger A, Schmid E, Kalender G et al. Bridge to recovery or
permanent system implantation: an eight-year single-center experience in
transvenous semipermanent pacing. Pacing Clin Electrophysiol
2013;36:1096-103.
25. Arias-Fernandez P, Romero-Martin M, Gomez-Salgado J,
Fernandez-Garcia D. Rehabilitation and early mobilization in the
critical patient: systematic review. J Phys Ther Sci 2018;30:1193-1201.
26. Lang JK, Paykel MS, Haines KJ, Hodgson CL. Clinical Practice
Guidelines for Early Mobilization in the ICU: A Systematic Review. Crit
Care Med 2020;48:e1121-e1128.
27. Merrer J, De Jonghe B, Golliot F et al. Complications of femoral and
subclavian venous catheterization in critically ill patients: a
randomized controlled trial. JAMA 2001;286:700-7.
28. Lau BD, Murphy P, Nastasi AJ et al. Effectiveness of ambulation to
prevent venous thromboembolism in patients admitted to hospital: a
systematic review. CMAJ Open 2020;8:E832-E843.
29. Garcia Guerrero JJ, Fernandez de la Concha Castaneda J, Lopez Quero
D et al. Lower incidence of venous thrombosis with temporary
active-fixation lead implantation in mobile patients. Europace
2010;12:1604-7.
30. Drug UFa. Class 2 Device Recall Medtronic, Temporary Pacing Lead
System. 2016.
31. Maisel WH, Hauser RG, Hammill SC et al. Recommendations from the
Heart Rhythm Society Task Force on Lead Performance Policies and
Guidelines: developed in collaboration with the American College of
Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm
2009;6:869-85.